Endoscopic Therapy of Neoplasia Related to Barrett's Esophagus and Endoscopic Palliation of Esophageal Cancer

Vignesh, Shivakumar; Hoffe, Sarah E.; Meredith, Kenneth; Shridhar, Ravi; Almhanna, Khaldoun; Gupta, Akshay

doi:10.1177/107327481302000205

Cited by 7 publications

(1 citation statement)

References 90 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of the use of PDT has been historical, [13][14][15][16][17] as has previously been mentioned, other modalities have supplanted its application, [18][19][20][21][22][23][24][25][26][27] in part because of its side effect profile (pain, esophageal stricturing, perforation, and cutaneous photosensitivity) and cost of the drug which can approximate $100,000 in the U.S., contingent upon patient weight. Nevertheless, there are a number of recent publications deserving of mention.…”

Section: Indications and Resultsmentioning

confidence: 99%

Photodynamic therapy in esophageal cancer

Kozarek

2015

Int J Gastrointest Interv

View full text Add to dashboard Cite

Historically, photodynamic therapy was an additional mechanism, along with external beam irradiation or brachytherapy, Nd:YAG laser tumor ablation or esophageal stent placement and to a lesser extent, chemotherapy, used to reestablish esophageal continuity in patients with esophageal malignancy who could not undergo resective surgery by virtue of infirmity or tumor stage. However, it has been virtually abandoned for this indication by most practitioners for over a decade. More recently, it has been used in the West to eradicate high-grade dysplasia and superficial malignancies arising in Barrett's esophagus, although its expense, limited availability, and side effect profile make widespread use unlikely, particularly given the widespread availability of other effective techniques. The latter include endoscopic submucosal resection, endoscopic submucosal dissection, radiofrequency ablation, and cryotherapy. This review highlights the historical use of photodynamic therapy in the treatment of esophageal malignancy and potential roles for its application in the future.

show abstract